share_log

香雪制药(300147.SZ):TAEST16001注射液目前在II期临床阶段

Xiangxue Pharmaceutical (300147.SZ): TAEST16001 injection is currently in Phase II clinical stage.

Gelonghui Finance ·  Nov 6 15:56

Gelonghui November 6th | xiangxue pharmaceutical (300147.SZ) stated on the investor interaction platform that TAEST16001 injection is currently in Phase II clinical stage. The progress of research and development will be disclosed to the public in the form of announcements based on clinical situations combined with information disclosure rules.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment